CYP46A1 and Alzheimer disease: CYP46*C (cholesterol 24-hydroxylase) along with APOE-4 was found associated with higher cognitive decline in AD and both variants synergistically increase the risk of AD [187–189] as well as brain and CSF Aβ load [190].